Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
Jade Biosciences, Inc. ( JBIO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 2:15 PM EST ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, announced a strategic collaboration with Polyphron, a company developing an autonomous ...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
January 5, 2026) Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the ...
AZoLifeSciences on MSN
LINE-1 retrotransposons reshape cancer genome architecture
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
IntroductionLegal education in India is not strictly an academic pursuit but an essential part of the justice delivery system ...
Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Summit Therapeutics Inc. ( SMMT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST ...
Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028DURHAM, N.C., Jan. 08, 2026 (GLOBE ...
Morning Overview on MSN
Beer waste makes cultivated meat taste more like the real thing
Scientists are turning a stubborn waste problem from the beer industry into a surprisingly effective tool for making ...
Helen Newlove's career in politics was driven by the death of her husband Garry, who was murdered by three youths in 2007. She served as Victims' Commissioner for England and Wales, a role she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results